XML 64 R7.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 4 Months Ended 6 Months Ended 12 Months Ended
Apr. 30, 2014
Jun. 30, 2014
Jun. 30, 2015
Apr. 30, 2014
Jun. 30, 2015
Dec. 31, 2014
Cash flows from financing activities            
Cash and cash equivalents at beginning of period         $ 163,405  
Cash and cash equivalents at end of period     $ 340,798   340,798 $ 163,405
Successor Company            
Net income (loss)   $ 45,144 38,278   (8,268)  
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:            
Net realized and unrealized (gain) loss on derivatives and foreign exchange   9,164 (15,859)   (6,759)  
Unrealized (depreciation) appreciation on investments allocable to noncontrolling interests   0     (8,776)  
Write-off of debt issuance costs   0     0  
Lower of cost or estimated fair value adjustment on corporate loans held for sale   0     0  
Impairment charges   0     0  
Share-based compensation   0     0  
Net realized and unrealized (gain) loss on investments   (54,100)     (4,715)  
Depreciation and net amortization   10,457     14,632  
Net realized and unrealized (gain) loss on debt   25,396 4,977   88,793  
Changes in assets and liabilities:            
Interest receivable   94     19,676  
Other assets   1,793     (23,241)  
Related party payable   4,740     (571)  
Accounts payable, accrued expenses and other liabilities   (21,190)     (4,731)  
Accrued interest payable   4,415     7,805  
Net cash provided by (used in) operating activities   25,913     73,845  
Cash flows from investing activities            
Principal payments from corporate loans   230,956     835,195  
Principal payments from securities   6,797     7,961  
Proceeds from sales of corporate loans   231,599     879,010  
Proceeds from sales of securities   1,806     137,617  
Proceeds from equity and other investments   24,409     11,869  
Purchases of corporate loans   (314,846)     (953,586)  
Purchases of securities   (32,478)     (9,387)  
Purchases of equity and other investments   (56,540)     (49,706)  
Net change in proceeds, purchases and settlements of derivatives   (2,627)     8,711  
Net change in restricted cash and cash equivalents   41,094     (456,140)  
Net cash provided by (used in) investing activities   130,170     411,544  
Cash flows from financing activities            
Issuance of collateralized loan obligation secured notes   52,594     539,746  
Retirement of collateralized loan obligation secured notes   (196,940)     (743,048)  
Distributions on common shares   (44,866)     (89,453)  
Distributions on preferred shares   0     (13,782)  
Capital contributions from Parent   466     0  
Capital contributions from noncontrolling interests   0     2,455  
Other capitalized costs   0     (3,914)  
Net cash (used in) provided by financing activities   (168,646)     (307,996)  
Net increase (decrease) in cash and cash equivalents   (12,563)     177,393  
Cash and cash equivalents at beginning of period         163,405  
Cash and cash equivalents at end of period   197,850 340,798   340,798 163,405
Supplemental cash flow information            
Cash paid for interest   24,196     83,937  
Net cash paid (refunded) for income taxes   59     103  
Non-cash investing and financing activities            
Preferred share distributions declared, not yet paid   6,891 $ 6,891   6,891  
Loans transferred from held for investment to held for sale   0     0  
Predecessor Company            
Net income (loss) $ (2,203)     $ 105,980    
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:            
Net realized and unrealized (gain) loss on derivatives and foreign exchange 1,413     9,783    
Unrealized (depreciation) appreciation on investments allocable to noncontrolling interests       0    
Write-off of debt issuance costs       1,472    
Lower of cost or estimated fair value adjustment on corporate loans held for sale       (5,038)    
Impairment charges       4,391    
Share-based compensation       1,018    
Net realized and unrealized (gain) loss on investments       (60,906)    
Depreciation and net amortization       15,832    
Net realized and unrealized (gain) loss on debt 0     0    
Changes in assets and liabilities:            
Interest receivable       (6,753)    
Other assets       (19,668)    
Related party payable       (1,815)    
Accounts payable, accrued expenses and other liabilities       27,211    
Accrued interest payable       (1,470)    
Net cash provided by (used in) operating activities       70,037    
Cash flows from investing activities            
Principal payments from corporate loans       906,166    
Principal payments from securities       21,223    
Proceeds from sales of corporate loans       36,595    
Proceeds from sales of securities       44,373    
Proceeds from equity and other investments       48,911    
Purchases of corporate loans       (886,230)    
Purchases of securities       (78,106)    
Purchases of equity and other investments       (104,301)    
Net change in proceeds, purchases and settlements of derivatives       (7,265)    
Net change in restricted cash and cash equivalents       (299,579)    
Net cash provided by (used in) investing activities       (318,213)    
Cash flows from financing activities            
Issuance of collateralized loan obligation secured notes       648,197    
Retirement of collateralized loan obligation secured notes       (221,914)    
Distributions on common shares       (45,061)    
Distributions on preferred shares       (13,782)    
Capital contributions from Parent       0    
Capital contributions from noncontrolling interests       0    
Other capitalized costs       (3,918)    
Net cash (used in) provided by financing activities       301,422    
Net increase (decrease) in cash and cash equivalents       53,246    
Cash and cash equivalents at beginning of period   210,413   157,167   $ 157,167
Cash and cash equivalents at end of period 210,413     210,413    
Supplemental cash flow information            
Cash paid for interest       53,576    
Net cash paid (refunded) for income taxes       157    
Non-cash investing and financing activities            
Preferred share distributions declared, not yet paid $ 0     0    
Loans transferred from held for investment to held for sale       348,808    
Other Credit Facilities | Successor Company            
Cash flows from financing activities            
Proceeds from credit facilities   20,100     0  
Repayment of credit facilities   0     0  
Other Credit Facilities | Predecessor Company            
Cash flows from financing activities            
Proceeds from credit facilities       13,300    
Repayment of credit facilities       (75,400)    
CLO Warehouse Facility | Successor Company            
Cash flows from financing activities            
Proceeds from credit facilities   0     190,000  
Repayment of credit facilities   $ 0     $ (190,000)  
CLO Warehouse Facility | Predecessor Company            
Cash flows from financing activities            
Proceeds from credit facilities       0    
Repayment of credit facilities       $ 0